Literature DB >> 7474149

The S2 subunit of the murine coronavirus spike protein is not involved in receptor binding.

F Taguchi1.   

Abstract

The receptor-binding capacity of the S2 subunit of the murine coronavirus S protein was examined by testing the inhibition of virus-receptor binding. Sp-4 virus and S1N(330), which consists of the N-terminal 330 amino acids of the S1 protein, both of which exhibited receptor-binding capacity, were able to prevent the binding of cl-2 virus to the receptor, while the mutant protein S1N(330)-159, which failed to bind to the receptor protein, and S2TM-, which lacks the transmembrane and cytoplasmic domains normally existing in the S2, were unable to prevent the binding of cl-2. By using cultured DBT cells, it was revealed that the infection of cells by cl-2 virus was significantly inhibited by S1N(330) but not by S2TM-. These results indicate that the S2 protein is not involved in the receptor binding of murine coronaviruses.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7474149      PMCID: PMC189649     

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  42 in total

1.  Structure of a human common cold virus and functional relationship to other picornaviruses.

Authors:  M G Rossmann; E Arnold; J W Erickson; E A Frankenberger; J P Griffith; H J Hecht; J E Johnson; G Kamer; M Luo; A G Mosser
Journal:  Nature       Date:  1985 Sep 12-18       Impact factor: 49.962

2.  Replication and plaque formation of mouse hepatitis virus (MHV-2) in mouse cell line DBT culture.

Authors:  N Hirano; K Fujiwara; S Hino; M Matumoto
Journal:  Arch Gesamte Virusforsch       Date:  1974

3.  Monoclonal antibodies to the S1 spike and membrane proteins of avian infectious bronchitis coronavirus strain Massachusetts M41.

Authors:  A P Mockett; D Cavanagh; T D Brown
Journal:  J Gen Virol       Date:  1984-12       Impact factor: 3.891

Review 4.  The biology and pathogenesis of coronaviruses.

Authors:  H Wege; S Siddell; V ter Meulen
Journal:  Curr Top Microbiol Immunol       Date:  1982       Impact factor: 4.291

5.  Proteolytic cleavage of peplomeric glycoprotein E2 of MHV yields two 90K subunits and activates cell fusion.

Authors:  L S Sturman; K V Holmes
Journal:  Adv Exp Med Biol       Date:  1984       Impact factor: 2.622

6.  Analysis of the functions of coronavirus glycoproteins by differential inhibition of synthesis with tunicamycin.

Authors:  K V Holmes; E W Doller; J N Behnke
Journal:  Adv Exp Med Biol       Date:  1981       Impact factor: 2.622

Review 7.  The biology of coronaviruses.

Authors:  S Siddell; H Wege; V Ter Meulen
Journal:  J Gen Virol       Date:  1983-04       Impact factor: 3.891

8.  Characterization of a variant virus selected in rat brains after infection by coronavirus mouse hepatitis virus JHM.

Authors:  F Taguchi; S G Siddell; H Wege; V ter Meulen
Journal:  J Virol       Date:  1985-05       Impact factor: 5.103

9.  Localization of neurovirulence determinant for rats on the S1 subunit of murine coronavirus JHMV.

Authors:  F Taguchi; H Kubo; H Takahashi; H Suzuki
Journal:  Virology       Date:  1995-04-01       Impact factor: 3.616

10.  Monoclonal antibodies to murine hepatitis virus-4 (strain JHM) define the viral glycoprotein responsible for attachment and cell--cell fusion.

Authors:  A R Collins; R L Knobler; H Powell; M J Buchmeier
Journal:  Virology       Date:  1982-06       Impact factor: 3.616

View more
  34 in total

1.  Amino acid substitutions within the leucine zipper domain of the murine coronavirus spike protein cause defects in oligomerization and the ability to induce cell-to-cell fusion.

Authors:  Z Luo; A M Matthews; S R Weiss
Journal:  J Virol       Date:  1999-10       Impact factor: 5.103

Review 2.  The molecular biology of coronaviruses.

Authors:  Paul S Masters
Journal:  Adv Virus Res       Date:  2006       Impact factor: 9.937

3.  Analysis of the receptor-binding site of murine coronavirus spike protein.

Authors:  H Suzuki; F Taguchi
Journal:  J Virol       Date:  1996-04       Impact factor: 5.103

4.  Receptor-independent infection of murine coronavirus: analysis by spinoculation.

Authors:  Rie Watanabe; Shutoku Matsuyama; Fumihiro Taguchi
Journal:  J Virol       Date:  2006-05       Impact factor: 5.103

5.  Identification of the membrane-active regions of the severe acute respiratory syndrome coronavirus spike membrane glycoprotein using a 16/18-mer peptide scan: implications for the viral fusion mechanism.

Authors:  Jaime Guillén; Ana J Pérez-Berná; Miguel R Moreno; José Villalaín
Journal:  J Virol       Date:  2005-02       Impact factor: 5.103

6.  The murine coronavirus mouse hepatitis virus strain A59 from persistently infected murine cells exhibits an extended host range.

Authors:  J H Schickli; B D Zelus; D E Wentworth; S G Sawicki; K V Holmes
Journal:  J Virol       Date:  1997-12       Impact factor: 5.103

7.  Identification of spike protein residues of murine coronavirus responsible for receptor-binding activity by use of soluble receptor-resistant mutants.

Authors:  K Saeki; N Ohtsuka; F Taguchi
Journal:  J Virol       Date:  1997-12       Impact factor: 5.103

8.  Identification of an antigenic determinant on the S2 domain of the severe acute respiratory syndrome coronavirus spike glycoprotein capable of inducing neutralizing antibodies.

Authors:  Hong Zhang; Guangwen Wang; Jian Li; Yuchun Nie; Xuanling Shi; Gewei Lian; Wei Wang; Xiaolei Yin; Yang Zhao; Xiuxia Qu; Mingxiao Ding; Hongkui Deng
Journal:  J Virol       Date:  2004-07       Impact factor: 5.103

9.  The coronavirus spike protein is a class I virus fusion protein: structural and functional characterization of the fusion core complex.

Authors:  Berend Jan Bosch; Ruurd van der Zee; Cornelis A M de Haan; Peter J M Rottier
Journal:  J Virol       Date:  2003-08       Impact factor: 5.103

10.  Amino acid substitutions in the S2 subunit of mouse hepatitis virus variant V51 encode determinants of host range expansion.

Authors:  Willie C McRoy; Ralph S Baric
Journal:  J Virol       Date:  2007-11-21       Impact factor: 5.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.